Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Calcification of the Aortic Arch
2000 Standout
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
1996
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Women have a larger and less atherogenic low density lipoprotein particle size than men
1996
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Acute paraplegia: A presenting manifestation of aortic dissection
1988
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women
1995
Distribution of lipids in 8,500 men with coronary artery disease
1995
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Exercise Standards for Testing and Training
2013 Standout
The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization
1999 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Clinical, Diagnostic, and Management Perspectives of Aortic Dissection
2002
Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography
1990
Cardiovascular Health and Disease in Women
1993
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article
2002 Standout
Effect on Survival of Estrogen Replacement Therapy After Coronary Artery Bypass Grafting
1997
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)
1993
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Biology of Incretins: GLP-1 and GIP
2007 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Diabetes and Atherosclerosis
2002 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction
2003
Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible Mechanisms
1995
Energy metabolism of the heart: From basic concepts to clinical applications applications
1994
Does hormone replacement therapy inhibit coronary artery calcification?
1997
A Rapid Diagnostic and Treatment Center for Patients With Chest Pain in the Emergency Department
1995
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Myocardial Reperfusion Injury
2007 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Estrogen, natriuretic peptides and the renin–angiotensin system
1999
Does reperfusion injury exist in humans?
1993
Production and Actions of Estrogens
2002 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Cost-Effectiveness of Mandatory Stress Testing in Chest Pain Center Patients
1997
Usefulness of Automated Serial 12-Lead ECG Monitoring During the Initial Emergency Department Evaluation of Patients With Chest Pain
1998
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
1996
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Prognostic significance of the admission electrocardiogram in acute myocardial infarction
1996
Glucose-Insulin-Potassium Therapy for Treatment of Acute Myocardial Infarction
1997
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
1990
Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
1991
Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.
1994
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Air Pollution and Cardiovascular Disease
2004 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
5 Oestrogens and atherosclerotic vascular disease—lipid factors
1993
Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning
1998
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
The AT 1 -Type Angiotensin Receptor in Oxidative Stress and Atherogenesis
2002
Estrogen Modulates AT1Receptor Gene Expression In Vitro and In Vivo
1998
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion
2004
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.
1993
Critical Analysis of Coronary Artery Bypass Graft Surgery: A 30-Year Journey
1998
Flexible and Stretchable Physical Sensor Integrated Platforms for Wearable Human‐Activity Monitoringand Personal Healthcare
2016 Standout
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
Estrogen Increases Bone Marrow–Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation
2003
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)
2002 Standout
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions.
1991
Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis
1997
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
1993 Standout
Endothelial Progenitor Cells
2004 Standout
Practice Standards for Electrocardiographic Monitoring in Hospital Settings
2004
Human vascular smooth muscle cells contain functional estrogen receptor.
1994
Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction
1999
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Differential Effects of Estrogen and Progesterone on AT1Receptor Gene Expression in Vascular Smooth Muscle Cells
2000
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
2009 Standout
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Works of Curtis E. Green being referenced
Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease
1991
Stability of multilead ST-segment “fingerprints” over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion
1988
Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women
1992
Ventricular arrhythmias during reperfusion
1986
Determinants of Cardiac Failure after Coronary Bypass Surgery within 30 Days of Acute Myocardial Infarction
1986
Noninvasive detection of coronary artery patency using continuous ST-segment monitoring
1986
Aortic dissection masquerading as acute myocardial infarction: Implication for thrombolytic therapy without cardiac catheterization
1984
Usefulness of the total cholesterol to high-density lipoprotein cholesterol ratio in predicting angiographic coronary artery disease in women
1991
Aortic dissection following coronary artery bypass surgery: Diagnosis by CT
1986
The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction
1986
Metabolic support during coronary reperfusion
1987